EUVIMEDEUVIMED entdecken
Open Access

Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo

Jake Pirkkanen, Sujeenthar Tharmalingam, Christopher Thome, Helen Chin Sinex, Laura V Benjamin, Adam C Losch, Anthony J Borgmann, Ryan M Dhaemers, Christopher Gordon, Douglas R Boreham, Marc S Mendonca

Radiation Research · 21.04.2023 · 200 (1) · 48-64

DOI: 10.1667/rade-22-00216.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Research, erschienen am 21.04.2023. Verfasst von Jake Pirkkanen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology. Hauptthemen laut MEDLINE: Cell Transformation, Neoplastic, Neoplasms, Radiation-Induced. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CGL1 human hybrid cell system has been utilized for many decades as an excellent cellular tool for investigating neoplastic transformation. Substantial work has been done previously implicating genetic factors related to chromosome 11 to the alteration of tumorigenic phenotype in CGL1 cells. This includes candidate tumor suppressor gene FOSL1, a member of the AP-1 transcription factor complex which encodes for protein FRA1. Here we present novel evidence supporting the role of FOSL1 in the suppression of tumorigenicity in segregants of the CGL1 system. Gamma-induced mutant (GIM) and control (CON) cells were isolated from 7 Gy gamma-irradiated CGL1s. Western, Southern and Northern blot analysis were utilized to assess FOSL1/FRA1 expression as well as methylation studies. GIMs were transfected to re-express FRA1 and in vivo tumorigenicity studies were conducted. Global transcriptomic microarray and RT-qPCR analysis were used to further characterize these unique cell segregants. GIMs were found to be tumorigenic in vivo when injected into nude mice whereas CON cells were not. GIMs show loss of Fosl/FRA1 expression as confirmed by Western blot. Southern and Northern blot analysis further reveals that FRA1 reduction in tumorigenic CGL1 segregants is likely due to transcriptional suppression. Results suggest that radiation-induced neoplastic transformation of CGL1 is in part due to silencing of the FOSL1 tumor suppressor gene promoter by methylation. The radiation-induced tumorigenic GIMs transfected to re-express FRA1 resulted in suppression of subcutaneous tumor growth in nude mice in vivo. Global microarray analysis and RT-qPCR validation elucidated several hundred differentially expressed genes. Downstream analysis reveals a significant number of altered pathways and enriched Gene Ontology terms genes related to cellular adhesion, proliferation, and migration. Together these findings provide strong evidence that FRA1 is a tumor suppressor gene deleted and epigenetically silenced after ionizing radiation-induced neoplastic transformation in the CGL1 human hybrid cell system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Transformation, NeoplasticNeoplasms, Radiation-InducedAnimalsMiceHumansMice, NudeHeLa CellsGenes, Tumor SuppressorCarcinogenesisPhenotypeGenomicsEpigenesis, GeneticGene Expression Regulation, Neoplastic

Autor:innen und Institutionen

  • Department of Biology.
  • Department of Biomolecular Sciences Program, Laurentian University, Sudbury, Ontario, P3E 2C6, Canada.
  • Medical Sciences Division, NOSM University, Sudbury, Ontario, P3E 2C6, Canada.
  • Department of Radiation Oncology, Radiation and Cancer Biology Laboratories, and Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202.
  • Bruce Power, PO Box 1540, 177 Tie Rd, R.R. 2, Tiverton, Ontario, N0G 2T0, Canada.
  • Nuclear Innovation Institute, Port Elgin, Ontario, N0H 2C0, Canada.

Förderung

  • NCI NIH HHS

Zitieren

APA

Pirkkanen, J., Tharmalingam, S., Thome, C., Sinex, H. C., Benjamin, L. V., Losch, A. C., Borgmann, A. J., Dhaemers, R. M., Gordon, C., Boreham, D. R., & Mendonca, M. S. (2023). Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo. Radiation Research, 200(1), 48-64. https://doi.org/10.1667/rade-22-00216.1

Vancouver

Pirkkanen J, Tharmalingam S, Thome C, Sinex HC, Benjamin LV, Losch AC, et al. Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo. Radiation Research. 2023;200(1):48-64. doi:10.1667/rade-22-00216.1

BibTeX
@article{Pirkkanen2023,
  author = {Pirkkanen, Jake and Tharmalingam, Sujeenthar and Thome, Christopher and Sinex, Helen Chin and Benjamin, Laura V and Losch, Adam C and Borgmann, Anthony J and Dhaemers, Ryan M and Gordon, Christopher and Boreham, Douglas R and Mendonca, Marc S},
  title = {Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo},
  journal = {Radiation Research},
  year = {2023},
  volume = {200},
  number = {1},
  pages = {48--64},
  doi = {10.1667/rade-22-00216.1}
}
Kostenlos starten →